STOCK TITAN

Precigen officer plans sale of 34,658 shares

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

PRECIGEN, INC. (PGEN) is the issuer for a Rule 144 notice filed on behalf of officer Rutul Shah. The notice covers a proposed sale of up to 34,658 shares of common stock on or after 08/21/2026, to be delivered from a stock option exercise through Fidelity Brokerage Services LLC. PRECIGEN common shares outstanding are listed as 358,035,247 as a reference figure.

Positive

  • None.

Negative

  • None.
Shares to be sold under Rule 144 34,658 shares Proposed sale of PRECIGEN common stock on or after 08/21/2026
Proposed aggregate sale price $259,935.00 Planned sale of 34,658 PRECIGEN common shares
Shares outstanding 358,035,247 shares PRECIGEN common shares listed as outstanding in securities information
Prior sale 1 42,924 shares for $251,105.40 Common stock sale on 06/29/2026 by Rutul Shah
Prior sale 2 33,772 shares for $219,518.00 Common stock sale on 08/03/2026 by Rutul Shah
Prior sale 3 32,739 shares for $224,589.54 Common stock sale on 08/06/2026 by Rutul Shah
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
stock option exercise financial
"Common | 08/21/2026 | Stock Option Exercise | Issuer"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.
attorney-in-fact regulatory
"as attorney-in-fact for Rutul Shah"
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.
common stock financial
"Common | Fidelity Brokerage Services LLC 900 Salem Street"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

What does the Form 144 filing disclose for PRECIGEN, INC. (PGEN)?

It discloses that officer Rutul Shah has filed a Rule 144 notice for a proposed sale of up to 34,658 shares of PRECIGEN common stock, to be issued from a stock option exercise and sold through Fidelity Brokerage Services LLC on or after 08/21/2026.

How many PRECIGEN (PGEN) shares are proposed to be sold under this Form 144?

The notice covers a proposed sale of up to 34,658 shares of PRECIGEN common stock, with a proposed aggregate sale price of $259,935.00, to be sold following a stock option exercise on or after 08/21/2026.

What prior sales by Rutul Shah in PGEN stock are reported in the last three months?

The filing reports three prior common stock sales: 42,924 shares for $251,105.40 on 06/29/2026, 33,772 shares for $219,518.00 on 08/03/2026, and 32,739 shares for $224,589.54 on 08/06/2026.

What is the listed number of PRECIGEN (PGEN) common shares outstanding in the Form 144?

The Form 144 lists 358,035,247 PRECIGEN common shares outstanding. This figure serves as a reference in the securities information section and is separate from the 34,658 shares covered by the proposed Rule 144 sale.

Who is executing the proposed Rule 144 sale for PRECIGEN (PGEN) shares?

The proposed sale of 34,658 PGEN shares is listed under Fidelity Brokerage Services LLC. The Form 144 is signed by Daniel Tucci as a duly authorized representative of Fidelity, acting as attorney-in-fact for Rutul Shah.

What is the nature of the shares to be sold in this PRECIGEN (PGEN) Form 144?

The shares are PRECIGEN common stock to be issued via a stock option exercise by the issuer and then sold for cash. The transaction date associated with both the exercise and the proposed sale is 08/21/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature